Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion.
暂无分享，去创建一个
K. Aldape | W. Mason | M. J. van den Bent | M. Weller | A. Brandes | T. Gorlia | M. Sanson | P. Wesseling | M. Vogelbaum | P. French | J. Kros | B. Baumert | H. Wheeler | S. Erridge | V. Golfinopoulos | J. Baurain | A. Nowak | P. Clement | W. Wick | M. Tesileanu